FDA Inspection 811161 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on December 10, 2012 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 10, 2012
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Hyde Park, NY (United States)